N. Bach

S. Friedman, J. Doucette, Jarone Lee, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Primary Biliary Cirrhosis: Environmental Risk Factors

J. Odin, N. Bach, Deepti Dronamraju, 2011, Disease markers.

Increased prevalence of primary biliary cirrhosis near superfund toxic waste sites

A. Branch, T. Schiano, A. Ala, 2006, Hepatology.

Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive.

M. Kreek, P. Farci, T. Croxson, 1988, The Journal of infectious diseases.

Transmission of hepatitis C: Sexual, vertical or exclusively blood‐borne?

H. Bodenheimer, N. Bach, 1992, Hepatology.

Comfrey herb tea-induced hepatic veno-occlusive disease.

F. Schaffner, S. Thung, N Bach, 1989, The American journal of medicine.

Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis

L. Zammataro, J. LaSalle, C. Selmi, 2011, Epigenetics.

Genome-Wide Analysis of DNA Methylation, Copy Number Variation, and Gene Expression in Monozygotic Twins Discordant for Primary Biliary Cirrhosis

M. Seldin, R. De Francesco, L. Zammataro, 2014, Front. Immunol..

HLA-DR expression in bile duct damage in hepatitis C.

F. Schaffner, S. Thung, M. Gerber, 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.

T. Schiano, P. Perumalswami, J. Doucette, 2015, World journal of gastroenterology.

Anti-CD16 autoantibodies and delayed phagocytosis of apoptotic cells in primary biliary cirrhosis.

C. Sautès-Fridman, J. Odin, Bin Hu, 2008, Journal of autoimmunity.

Exaggerated cholestasis and hepatic fibrosis following simultaneous administration of chlorpromazine and sodium valproate

F. Schaffner, S. Thung, H. Tobias, 1989, Digestive Diseases and Sciences.

Methotrexate Therapy for Primary Biliary Cirrhosis

C. Bodian, K. Lindor, F. Schaffner, 2003, American Journal of Gastroenterology.

Atorvastatin Does Not Improve Liver Biochemistries or Mayo Risk Score in Primary Biliary Cirrhosis

C. Bodian, H. Bodenheimer, J. Odin, 2008, Digestive Diseases and Sciences.

ORIGINAL ARTICLES—LIVER, PANCREAS, AND BILIARY TRACT Transplantation Trends in Primary Biliary Cirrhosis

S. Friedman, J. Doucette, Jarone Lee, 2007 .

Evaluation of Fatigue in U.S. Patients with Primary Biliary Cirrhosis

A. Branch, C. Bodian, P. Berk, 2005, The American Journal of Gastroenterology.

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study.

William M. Lee, Huiman X. Barnhart, Robert J. Fontana, 2015, Gastroenterology.

The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis.

F. Schaffner, S. Thung, N. Bach, 1998, Archives of pathology & laboratory medicine.

Gastrointestinal Syndromes in Primary Biliary Cirrhosis

F. Schaffner, N. Bach, 1988, Seminars in liver disease.

HIGH-DOSE RECOMBINANT INTERLEUKIN-2 FOR CHRONIC VIRAL HEPATITIS

F. Schaffner, Shee‐Chan Lin, N. Bach, 1989, The Lancet.

Hepatology: A textbook of liver diseases. 2nd ed. Edited by D. Zakim and T.D. Boyer, 1,568 pp. Philadelphia: W.B. Saunders Co., 1989. $225 per set

R. Koff, N. Bach, 1991 .

Hepatocellular carcinoma associated with autoimmune chronic active hepatitis.

F. Schaffner, S. Thung, N. Bach, 1990, The Mount Sinai journal of medicine, New York.